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Bleeding remains a serious complication of cardiac surgery. 
Studies indicate that preoperative fibrinogen concentration is 
an independent predictor of blood loss during coronary artery 
bypass graft (CABG) surgery. This study evaluates whether 
fibrinogen concentration is a better predictor of blood usage than 
the prothrombin time (PT) and activated partial thromboplastin 
time (aPTT) tests. Patients not taking clopidogrel bisulfate who 
underwent CABG surgery during a 3-month period at a 350-bed 
community hospital were included in this prospective study. 
The parameters evaluated included patient’s age, preoperative 
coagulation test results (PT, international normalized ratio [INR], 
aPTT, fibrinogen), and number of blood components transfused. 
A probability value of less than 0.05 was deemed significant. 
Thirty-five patients were included in this study. Mean blood usage 
was 6 units. Patient’s age approached significance as a predictor 
of blood usage, and fibrinogen levels trended toward significance 
more than the other coagulation parameters. In this study, the 
increased age of the patient and low plasma concentrations of 
fibrinogen were associated with increased blood usage. Although 
no indicators clearly demonstrated statistical significance, 
the vast difference in the probability values for patients’ ages 
and fibrinogen levels indicated that there was a trend toward 
significance in blood usage for CABG patients. Further studies with 
larger patient populations are indicated. Immunohematology 
2011;27:151–153.
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Hemostasis continues to be a challenge in coronary artery 
bypass graft (CABG) surgery. Preoperative predictors of blood 
usage have been elusive. A patient’s preoperative coagulation 
status has been touted as a potential gauge of intraoperative 
and postoperative bleeding. Recent studies indicate that 
preoperative plasma fibrinogen levels are independent 
predictors of blood loss in patients undergoing CABG surgery.1
Plasma fibrinogen plays a key role in hemostasis after 
platelet activation and aggregation. Fibrinogen is the key to 
platelet stabilization and strengthening of the thrombus to 
ensure that bleeding stops and the healing process begins. 
Fibrinogen’s major contribution to clotting is in the common 
pathway of coagulation, in which it forms a stable fibrin 
clot.2–5 The fibrinogen test is a measure of the concentration of 
available fibrinogen in the body plasma at a given time. Because 
fibrinogen is not stored in any great quantity in any cells and it 
is a consumable component of whole blood, fibrinogen’s major 
reserve is in the plasma. Fibrinogen constitutes approximately 
2 percent of the total plasma protein concentration.2,3
The prothrombin time (PT) and the activated partial 
thromboplastin time (aPTT) are routine coagulation tests 
used to determine whether patients have abnormalities in 
blood clotting. The PT value is a measure of the extrinsic 
pathway of clotting, whereas the aPTT is a measure of the 
intrinsic pathway of coagulation. Both the intrinsic and 
extrinsic systems include the common pathway of clotting and 
terminate with the successful formation of a fibrin clot.2–5
The aim of this study was to determine whether the 
preoperative fibrinogen concentration was a better predictor 
of blood component usage during hospitalization than the 
traditional PT and aPTT tests in patients not taking clopidogrel 
bisulfate (Plavix) and undergoing CABG surgery.
Materials and Methods
This study was conducted at a 350-bed community 
hospital serving a midsized city and surrounding communities 
with a population of greater than 100,000 inhabitants. 
Patients undergoing CABG surgery and not taking clopidogrel 
bisulfate were eligible to be included in this prospective 
study. Clopidogrel bisulfate is an inhibitor of adenosine 
diphosphate–induced platelet aggregation, thus preventing 
platelet aggregation or clot formation. Clopidogrel bisulfate is 
associated with increased bleeding tendencies, and therefore 
patients taking this drug were excluded from the study.
The data analysis occurred during a period of 3 months. 
No consideration was given to patient’s sex or race. This study 
did not distinguish between the types of blood components 
used and included packed red blood cells, platelets, fresh-
frozen plasma, and cryoprecipitated AHF.
The parameters evaluated in this study included patient’s 
age, preoperative coagulation test results (PT, international 
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normalized ratio [INR], aPTT, and fibrinogen), and total blood 
components used during hospitalization. All coagulation 
testing was performed on a Stago Compact Analyzer 
(Diagnostica Stago, Inc., Parsippany, NJ).
Statistics
Outcomes were compared using the t test, and correlation 
between parameters and blood usage, r values, were calculated. 
A probability value of less than 0.05 was deemed statistically 
significant.6,7
Results
A total of 35 patients (n = 35) with a mean age of 67 years 
(range, 52 to 85 years) undergoing CABG procedures and not 
on clopidogrel bisulfate were included in this study. The mean 
number of blood components transfused was 6 units (range, 0 
to 22 units).
Linear regression showed that a relationship existed 
between patient age and blood component usage (Fig. 1). An 
inverse relation existed between fibrinogen level and blood 
component usage (Fig. 2). The PT, INR, and aPTT results 
compared with the blood components transfused did not 
demonstrate a relationship (Figs. 3–5).
The correlation and probability values for each indicator 
evaluated (age, PT/INR, aPTT, and fibrinogen levels as 
compared with blood component consumption) are as follows: 
age (r = 0.3191; p = 0.062), PT (r = –0.0223; p = 0.898), INR 
(r = –0.0120; p = 0.945), aPTT (r = 0.0060; p = 0.973), and 
fibrinogen (r = –0.2541; p = 0.141). Although the PT/INR 
and aPTT levels did not show any significance in predicting 
blood component consumption, patient’s age approached 
significance as a predictor of blood usage, and fibrinogen levels 
trended toward significance more than the other coagulation 
parameters.
Discussion
The results of this study indicate that increased patient age 
and a low preoperative plasma fibrinogen level were indicators 
associated with increased blood component consumption 
during and after CABG surgery. According to this data analysis, 
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Figure 3. Analysis of total blood components transfused by patient’s 














Figure 4. Analysis of total blood components transfused by patient’s 
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Predicting blood usage in CABG surgery
there were no indicators clearly demonstrating statistical 
significance. However, the vast difference in the probability 
values for patient age and fibrinogen level as compared with 
those for the other tests suggests that there is a relationship 
predicting blood and blood component usage in CABG 
patients. Increased patient age and blood usage approached 
significance, and decreasing fibrinogen levels and blood usage 
trended toward significance.
The prediction of blood usage in CABG surgery has been 
an area of interest for more than 25 years. Numerous groups 
have developed algorithms and prediction rules for use as 
tools to predict the probability of clinical bleeding in CABG 
patients.8–13 Methods of testing coagulation parameters have 
been evaluated to determine which method was the most 
useful in given populations of patients.14,15 Several of these 
studies were contradictory; experiences, accuracy of test 
results, and clinical usefulness were variable.
In part, this study supports the observations of Karlsson 
and colleagues that preoperative fibrinogen concentrations 
can be used to identify patients with an increased likelihood 
of severe bleeding after CABG surgery.1 Multicenter studies 
with larger populations of CABG patients are warranted to 
determine whether a significant correlation exists among 
these parameters and whether these findings can be 
generalized. Subset analyses by specific blood components 
may provide additional insight to potential predictors of 
transfusion. Prediction of blood usage in CABG cases would 
assist physicians and the blood bank in proper preparation 
and support of patients undergoing CABG surgery.
References
 1. Karlsson M, Ternström L, Hyllner M, Baghaei F, Nilsson S, 
Jeppsson A. Plasma fibrinogen level, bleeding, and transfusion 
after on-pump coronary artery bypass grafting surgery: a 
prospective observational study. Transfusion 2008;48:2152–8.
 2. O’Malley BA. Primary hemostasis. In: McKenzie SB, Williams 
JL, eds. Clinical laboratory hematology. 2nd ed. Upper Saddle 
River, NJ: Pearson Education Inc., 2010:612–38.
 3. O’Malley BA. Secondary hemostasis and fibrinolysis. In: 
McKenzie SB, Williams JL, eds. Clinical laboratory hematology. 
2nd ed. Upper Saddle River, NJ: Pearson Education Inc., 2010: 
639–70.
 4. Harmening DM, Escobar CE, McGlasson DL. Introduction to 
hemostasis. In: Harmening DM, ed. Clinical hematology and 
fundamentals of hemostasis 5th ed. Philadelphia, PA: FA Davis 
Co., 2009:543-76.
 5. Ehsan A, Herrick JL. Introduction to thrombosis and 
anticoagulant therapy. In: Harmening DM, ed. Clinical hema-
tology and fundamentals of hemostasis 5th ed. Philadelphia, 
PA: FA Davis Co., 2009:660-5.
 6. Bluman AG. Hypothesis testing. In: Weiss NA, ed. Elementary 
statistics. 6th ed. New York, NY: McGraw-Hill, 2007:391–453.
 7. Bluman AG. Correlation and regression. In: Weiss NA, ed. 
Elementary statistics. 6th ed. New York, NY: McGraw-Hill, 
2007:527–75.
 8.  Karkouti K, Wijeysundera DN, Beattie WS, et al. Variability 
and predictability of large-volume red blood cell transfusion 
in cardiac surgery: a multicenter study. Transfusion 2007;47: 
2081–8.
 9. Tinmouth AT. The value of a clinical prediction rule for 
allogeneic transfusion in cardiac surgery. Transfusion 2006;46: 
1072–4.
 10. Alghamdi A, Davis A, Brister S, Corey P, Logan A. Development 
and validation of Transfusion Risk Understanding Tool 
(TRUST) to stratify cardiac surgery patients according to their 
blood transfusion needs. Transfusion 2006;46:1120–9.
 11. Covin R, O’Brien M, Grunwald G, et al. Factors affecting 
transfusion of fresh frozen plasma, platelets, and red blood 
cells during elective coronary artery bypass graft surgery. Arch 
Pathol Lab Med 2003;127:415–23.
 12. Karkouti K, O’Farrell R, Yau TM, Beattie WS; Reducing 
Bleeding in Cardiac Surgery Research Group. Prediction of 
massive blood transfusion in cardiac surgery. Can J Anaesth 
2006;53:781–94.
 13. Despotis G, Avidan M, Eby C. Prediction and management 
of bleeding in cardiac surgery. J Thromb Haemost 2009;7 
(Suppl 1):111–17.
 14. Shih RL, Cherng YG, Chao A, Chen JT, Tsai AL, Liu CC. 
Prediction of bleeding diathesis in patients undergoing 
cardiopulmonary bypass during cardiac surgery: viscoelastic 
measures versus routine coagulation test. Acta Anaesthesiol 
Sin 1997;35:133–9.
 15. Wang JS, Lin CY, Hung WT, et al. Thromboelastogram fails 
to predict postoperative hemorrhage in cardiac patients. Ann 
Thorac Surg 1992;53:435–9.
Shana Josefy, MT(ASCP)SBBCM and Ricardo Briones, MT(ASCP)CM, 
United Regional Health Care System, Wichita Falls, TX, and Barbara 
J. Bryant, MD (corresponding author), University of Texas Medical 
Branch, Department of Pathology, Blood Bank Division, 301 University 
Boulevard, Route 0717, Galveston, TX 77555-0717.
Figure 5. Analysis of total blood components transfused by patient’s 
preoperative activated partial thromboplastin time (aPTT) value.
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